Eric Liang

Rani Therapeutics (United States)

Papers

1

Total Citations

94

H-Index

1

About

Eric Liang is a pioneering biomedical engineer whose research centers on the development of novel drug delivery systems, with a particular focus on transforming the administration of biotherapeutics. His most notable contribution is the invention of a robotic pill designed for the oral delivery of large-molecule drugs, a breakthrough that directly addresses the longstanding challenge of patient non-compliance with chronic injections. This work, detailed in his highly cited 2021 paper (94 citations), demonstrates the safety, tolerability, and performance of the device in healthy subjects, offering a painless alternative to traditional injections for conditions requiring frequent biologic therapy. Liang’s research sits at the intersection of mechanical engineering, gastroenterology, and pharmaceutical science, and his achievements have been recognized for their potential to dramatically improve the quality of life for patients managing chronic diseases. By engineering a solution that bypasses the gastrointestinal tract's natural barriers, he has opened a new frontier in oral biotherapeutic delivery, making his work a cornerstone for future innovations in non-invasive drug administration.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects
94 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Rani Therapeutics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago